Publication

Number of items: 4.
February 2012
  • Pharmacologic Profile of OC000459, a Potent, Selective, and Orally Active D Prostanoid Receptor 2 Antagonist That Inhibits Mast Cell-Dependent Activation of T Helper 2 Lymphocytes and Eosinophils. (2012) Roy Pettipher, Shan L. Vinall, Luzheng Xue, Graham Speight, Elizabeth R. Townsend, Lucien Gazi, C.J. Whelan, Richard E. Armer, Mark A. Payton and Michael G. Hunter
    • December 2006
  • In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates, the selective 5-hydroxytryptamine 1a agonist (R)-(+)-8-OHDPAT inhibits levodopa-induced dyskinesia but only with\increased motor disability. (2006) Mahmoud M. Iravani, Kayhan Tayarani-Binazir, Wing B. Chu, Michael J. Jackson and Peter Jenner
    • 22 February 1995
  • Separation of immunomodulatory and cholesterol-lowering activities of heterocyclic azaspiranes. (1995) C. R. Albrightson, P. J. Bugelski, Theo Berkhout, B. Jackson, William D. Kerns, A.J. Organ and A. M. Badger
    • 1995
  • Increases in non-N-methyl-D-aspartate glutamatergic transmission, but no change in gamma-aminobutyric acid(B) transmission, in CA1 neurons during withdrawal from in-vivo chronic ethanol treatment. (1995) A. Molleman and H.J. Little
    • This list was generated on Wed Oct 14 03:19:48 2026 BST.